Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

Bibliografiska uppgifter
Huvudupphovsmän: Moran, A, Ramakrishnan, S, Borg, C, Connolly, C, Couillard, S, Mwasuku, C, Pavord, I, Hinks, T, Lehtimaki, L
Materialtyp: Conference item
Språk:English
Publicerad: European Respiratory Society 2020
_version_ 1826293165366181888
author Moran, A
Ramakrishnan, S
Borg, C
Connolly, C
Couillard, S
Mwasuku, C
Pavord, I
Hinks, T
Lehtimaki, L
author_facet Moran, A
Ramakrishnan, S
Borg, C
Connolly, C
Couillard, S
Mwasuku, C
Pavord, I
Hinks, T
Lehtimaki, L
author_sort Moran, A
collection OXFORD
description
first_indexed 2024-03-07T03:25:54Z
format Conference item
id oxford-uuid:b904b7d9-9123-4b7d-a3da-7c2c76246d6b
institution University of Oxford
language English
last_indexed 2024-03-07T03:25:54Z
publishDate 2020
publisher European Respiratory Society
record_format dspace
spelling oxford-uuid:b904b7d9-9123-4b7d-a3da-7c2c76246d6b2022-03-27T05:00:05ZDepletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthmaConference itemhttp://purl.org/coar/resource_type/c_c94fuuid:b904b7d9-9123-4b7d-a3da-7c2c76246d6bEnglishSymplectic ElementsEuropean Respiratory Society2020Moran, ARamakrishnan, SBorg, CConnolly, CCouillard, SMwasuku, CPavord, IHinks, TLehtimaki, L
spellingShingle Moran, A
Ramakrishnan, S
Borg, C
Connolly, C
Couillard, S
Mwasuku, C
Pavord, I
Hinks, T
Lehtimaki, L
Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
title Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
title_full Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
title_fullStr Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
title_full_unstemmed Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
title_short Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma
title_sort depletion rate of blood eosinophils with mepolizumab benralizumab and oral prednisolone in patients with severe asthma
work_keys_str_mv AT morana depletionrateofbloodeosinophilswithmepolizumabbenralizumabandoralprednisoloneinpatientswithsevereasthma
AT ramakrishnans depletionrateofbloodeosinophilswithmepolizumabbenralizumabandoralprednisoloneinpatientswithsevereasthma
AT borgc depletionrateofbloodeosinophilswithmepolizumabbenralizumabandoralprednisoloneinpatientswithsevereasthma
AT connollyc depletionrateofbloodeosinophilswithmepolizumabbenralizumabandoralprednisoloneinpatientswithsevereasthma
AT couillards depletionrateofbloodeosinophilswithmepolizumabbenralizumabandoralprednisoloneinpatientswithsevereasthma
AT mwasukuc depletionrateofbloodeosinophilswithmepolizumabbenralizumabandoralprednisoloneinpatientswithsevereasthma
AT pavordi depletionrateofbloodeosinophilswithmepolizumabbenralizumabandoralprednisoloneinpatientswithsevereasthma
AT hinkst depletionrateofbloodeosinophilswithmepolizumabbenralizumabandoralprednisoloneinpatientswithsevereasthma
AT lehtimakil depletionrateofbloodeosinophilswithmepolizumabbenralizumabandoralprednisoloneinpatientswithsevereasthma